Newron Pharmaceuticals S.p.A.
Save
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Newron Pharmaceuticals S.p. A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia.

Similar securities

Based on sector and market capitalization

Report issue